Investor Insights

Arboreal Bioinnovations Is Rewriting India’s Ingredient Story

Arboreal Bioinnovations Is Rewriting India's Ingredient Story

On a humid July morning in Lucknow, a team of scientists at Biotech Park watched their phones light up with notifications from investors across the country. The news spread fast: Arboreal Bioinnovations, the specialty food and nutraceutical ingredients startup they had built from scratch, had just closed one of the largest Series A rounds in India’s specialty food ingredients sector. The ₹230 crore ($24.09 million) investment, co-led by EAAA Alternatives (the alternatives arm of Edelweiss) and Omnivore, with continued backing from existing investor Rainmatter by Zerodha, wasn’t just a funding milestone—it was a signal.

For a country that has historically been a net importer of food ingredients and industrial biotechnology, Arboreal’s rise represents something more significant: the emergence of India as a credible originator of advanced food science.

The Founding Story: Engineers with a Mission

Arboreal was founded in 2018 by Swati Pandey and Manish Chauhan, two engineers who saw an opportunity where others saw a problem. India’s food and beverage industry was growing rapidly, but the ingredient supply chain remained fragmented, heavily import-dependent, and ill-equipped to meet the rising demand for clean-label, functional, and science-backed nutrition.

Pandey, an engineer turned entrepreneur, had a clear mission: create a Type 2 diabetes and obesity-free world through better food ingredients. Chauhan brought deep operational expertise to complement that vision. Together, they built a company that would bridge the gap between India’s agricultural abundance and the global demand for next-generation functional ingredients.

Their team reflects the depth of India’s scientific talent. Arboreal is founded by an award-winning team of graduates from IITs, BITS Pilani, University of Cambridge, University of Helsinki, London Business School, and Imperial College London. This is not a company that stumbled into success—it was engineered for it.

The Technology Platform: Engineering Clean Nutrition

Arboreal operates a comprehensive technology platform spanning ingredient engineering, process R&D, formulation science, and precision manufacturing. The company has developed proprietary ingredients across several categories:

  • Yeast and plant proteins—including its Bioprot label, which supplies fermented yeast protein to Indian nutrition brands
  • Zero-calorie natural sweeteners—alternatives to refined sugar
  • Cocoa-based ingredients
  • Functional fibres
  • Marine collagen and other emerging platforms

The company’s impact is already measurable. Arboreal reports supplying more than 1,100 business customers in India, with its ingredients featuring in over 300 product launches during the past 18 months. Its yeast protein, in particular, has gained visibility through partnerships with popular Indian brands including SuperYou, Cosmix, and Yoga Bar (Sprout Life Foods). In January 2026, Starbucks India introduced a Protein Cold Foam built on yeast protein from SuperYou—a brand that Arboreal reportedly supplies.

The Market Opportunity: India’s $5 Billion Functional Ingredients Market

The timing of Arboreal’s funding reflects a broader transformation in India’s food industry. The country’s functional food ingredients market is valued at approximately **$4.5–5.2 billion in 2026**, driven by a rapidly urbanizing population and rising discretionary spending on preventive healthcare. The multifunctional food ingredients market alone is estimated at $1.8–2.1 billion, driven by the convergence of clean-label reformulation and supply-chain simplification.

Consumer preferences are shifting decisively. A recent report found that 61% of Indian consumers prefer snacks made with natural ingredients like dates and jaggery over refined sugar, reflecting a growing demand for cleaner labels and healthier alternatives. Young Indians are embracing “Quick Nutrition”—prioritising protein, clean labels, and functional foods over restrictive diets.

This is the market Arboreal is positioned to serve. As Jinesh Shah, Managing Partner at Omnivore, noted: “The shift toward clean-label and functional foods requires engineered ingredients that deliver clear health benefits without sacrificing taste or margins. From sweetener alternatives to novel yeast proteins and collagens, Arboreal’s R&D stack positions them to power the next wave of health and wellness brands”.

What the Capital Will Enable

The ₹230 crore funding will be deployed across three strategic priorities:

  1. Expanding manufacturing capacity—to meet growing demand from domestic and international customers
  2. Strengthening research and development—building on Arboreal’s existing R&D capabilities to develop next-generation ingredients
  3. Accelerating commercialisation—bringing new functional ingredients to market faster

Ashish Agarwal, Managing Director of Private Equity at EAAA Alternatives, described the investment as the first from the firm’s Discovery Fund II, noting: “The investment in Arboreal reflects the core philosophy of our Fund’s strategy—backing businesses with the potential to emerge as category leaders”.

Rainmatter’s Dinesh Pai framed the backing around a deeper national imperative: “We all lament that India does not allocate capital for enough R&D. We truly wanted to back Swati and Manish in building a world-class R&D team working on food ingredients from India. We believe that they are the right team, with exceptional grit to chase down this problem”.

The Bigger Picture: India’s Biotech and Deep-Tech Moment

Arboreal’s success is part of a larger story. Indian startups have now raised **$7.95 billion across 567 rounds in 2026 so far**. The week of Arboreal’s funding saw 14 Indian startups raise over $79.79 million, with Arboreal accounting for nearly 30% of the week’s total capital.

More importantly, the government is creating the policy infrastructure for this growth. The ₹1 lakh crore Research, Development and Innovation (RDI) Scheme is providing long-term, patient capital for deep-tech ventures. The BIRAC–RDI Fund, a ₹2,000 crore initiative, is supporting biotech startups from proof-of-concept to commercial-scale manufacturing. The government has also extended the duration for which deep-tech firms can retain startup status from 10 to 20 years, while increasing the turnover eligibility threshold from ₹100 crore to ₹300 crore.

Uttar Pradesh, where Arboreal is headquartered, is also stepping up. The state has earmarked an initial ₹100 crore for U-Hub, a deep-tech innovation hub that will provide advanced laboratories, shared research infrastructure, prototyping facilities, and global networking opportunities. The Cabinet has also cleared deep-tech hubs in Lucknow and Noida, focusing on quantum computing, semiconductor design, and advanced technologies.

A Vision for India’s Ingredient Future

Swati Pandey captured the ambition of the moment: “This fundraise is a strong validation of the direction we are taking as a company. It gives us the fuel to accelerate our mission of building clean, science-led solutions that address some of the world’s most pressing nutritional and food challenges, with innovation originating in India and reaching consumers globally”.

Arboreal has already doubled its growth year-on-year. With fresh capital, expanded manufacturing capacity, and a strengthened R&D team, the company is poised to scale—not just in India, but globally.

The Lucknow-based startup’s journey is a reminder that India’s deep-tech story is no longer confined to Bengaluru or Hyderabad. From the laboratories of Biotech Park to the menus of Starbucks, Arboreal is proving that world-class ingredient innovation can emerge from anywhere in India—and compete anywhere in the world.

Leave a Reply

Your email address will not be published. Required fields are marked *